🇺🇸 FDA
Pipeline program

TNG462

TNG462-C101

Phase 2 small_molecule active

Quick answer

TNG462 for Locally Advanced Solid Tumor is a Phase 2 program (small_molecule) at Tango Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Tango Therapeutics
Indication
Locally Advanced Solid Tumor
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials